XML 73 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

FAIR VALUE (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
Schedule of Valuation of Investments and Other Financial Instruments by Fair Value Hierarchy Levels | The following tables summarize the financial assets and financial liabilities measured at fair value for the Company and the Consolidated Funds as of March 31, 2025:
Financial Instruments of the Company |  | Level I |  | Level II |  | Level III |  | Investments Measured at NAV |  | Total
Assets, at fair value |  |  |  |  |  |  |  |  |  |
Investments: |  |  |  |  |  |  |  |  |  |
Common stock and other equity securities |  | $ | 77,066 |  |  | $ | 141,084 |  |  | $ | 426,377 |  |  | $ | — |  |  | $ | 644,527 |
Collateralized loan obligations and fixed income securities |  | — |  |  | — |  |  | 18,662 |  |  | — |  |  | 18,662 |
Partnership interests |  | — |  |  | — |  |  | — |  |  | 238 |  |  | 238 |
Total investments, at fair value |  | 77,066 |  |  | 141,084 |  |  | 445,039 |  |  | 238 |  |  | 663,427 |
Derivatives-foreign currency forward contracts |  | — |  |  | 1,496 |  |  | — |  |  | — |  |  | 1,496 |
Total assets, at fair value |  | $ | 77,066 |  |  | $ | 142,580 |  |  | $ | 445,039 |  |  | $ | 238 |  |  | $ | 664,923 |
Liabilities, at fair value |  |  |  |  |  |  |  |  |  |
Derivatives-foreign currency forward contracts |  | $ | — |  |  | $ | (902) |  |  | $ | — |  |  | $ | — |  |  | $ | (902) |
Contingent consideration |  | — |  |  | — |  |  | (484,954) |  |  | — |  |  | (484,954) |
Total liabilities, at fair value |  | $ | — |  |  | $ | (902) |  |  | $ | (484,954) |  |  | $ | — |  |  | $ | (485,856) |
Financial Instruments of the Consolidated Funds |  | Level I |  | Level II |  | Level III |  | Investments Measured at NAV |  | Total
Assets, at fair value |  |  |  |  |  |  |  |  |  |
Investments: |  |  |  |  |  |  |  |  |  |
Fixed income investments: |  |  |  |  |  |  |  |  |  |
Loans and securitization vehicles |  | $ | — |  |  | $ | 6,302,334 |  |  | $ | 578,384 |  |  | $ | — |  |  | $ | 6,880,718 |
Money market funds |  | 556,498 |  |  | — |  |  | — |  |  | — |  |  | 556,498 |
Bonds |  | — |  |  | 341,532 |  |  | 2,608 |  |  | — |  |  | 344,140 |
Total fixed income investments |  | 556,498 |  |  | 6,643,866 |  |  | 580,992 |  |  | — |  |  | 7,781,356 |
Partnership interests |  | — |  |  | — |  |  | — |  |  | 2,318,557 |  |  | 2,318,557 |
Equity securities |  | 29,484 |  |  | 2,002 |  |  | 1,844,907 |  |  | — |  |  | 1,876,393 |
Total investments, at fair value |  | 585,982 |  |  | 6,645,868 |  |  | 2,425,899 |  |  | 2,318,557 |  |  | 11,976,306 |
Derivatives-foreign currency forward contracts |  | — |  |  | 9,668 |  |  | — |  |  | — |  |  | 9,668 |
Total assets, at fair value |  | $ | 585,982 |  |  | $ | 6,655,536 |  |  | $ | 2,425,899 |  |  | $ | 2,318,557 |  |  | $ | 11,985,974 |
Liabilities, at fair value |  |  |  |  |  |  |  |  |  |
Loan obligations of CLOs |  | $ | — |  |  | $ | (8,522,002) |  |  | $ | — |  |  | $ | — |  |  | $ | (8,522,002) |
Derivatives: |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | — |  |  | (9,890) |  |  | — |  |  | — |  |  | (9,890) |
Asset swaps |  | — |  |  | — |  |  | (749) |  |  | — |  |  | (749) |
Total derivative liabilities, at fair value |  | — |  |  | (9,890) |  |  | (749) |  |  | — |  |  | (10,639) |
Total liabilities, at fair value |  | $ | — |  |  | $ | (8,531,892) |  |  | $ | (749) |  |  | $ | — |  |  | $ | (8,532,641) |
The following tables summarize the financial assets and financial liabilities measured at fair value for the Company and the Consolidated Funds as of December 31, 2024:
Financial Instruments of the Company |  | Level I |  | Level II |  | Level III |  | Investments Measured at NAV |  | Total
Assets, at fair value |  |  |  |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 1,071,071 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1,071,071 |
Investments: |  |  |  |  |  |  |  |  |  |
Common stock and other equity securities |  | — |  |  | 104,037 |  |  | 411,179 |  |  | — |  |  | 515,216 |
Collateralized loan obligations and fixed income securities |  | — |  |  | — |  |  | 41,833 |  |  | — |  |  | 41,833 |
Partnership interests |  | — |  |  | — |  |  | — |  |  | 238 |  |  | 238 |
Total investments, at fair value |  | — |  |  | 104,037 |  |  | 453,012 |  |  | 238 |  |  | 557,287 |
Derivatives-foreign currency forward contracts |  | — |  |  | 3,737 |  |  | — |  |  | — |  |  | 3,737 |
Total assets, at fair value |  | $ | 1,071,071 |  |  | $ | 107,774 |  |  | $ | 453,012 |  |  | $ | 238 |  |  | $ | 1,632,095 |
Liabilities, at fair value |  |  |  |  |  |  |  |  |  |
Derivatives-foreign currency forward contracts |  | $ | — |  |  | $ | (216) |  |  | $ | — |  |  | $ | — |  |  | $ | (216) |
Contingent consideration |  | — |  |  | — |  |  | (17,550) |  |  | — |  |  | (17,550) |
Total liabilities, at fair value |  | $ | — |  |  | $ | (216) |  |  | $ | (17,550) |  |  | $ | — |  |  | $ | (17,766) |
Financial Instruments of the Consolidated Funds |  | Level I |  | Level II |  | Level III |  | Investments Measured at NAV |  | Total
Assets, at fair value |  |  |  |  |  |  |  |  |  |
Investments: |  |  |  |  |  |  |  |  |  |
Fixed income investments: |  |  |  |  |  |  |  |  |  |
Loans and securitization vehicles |  | $ | — |  |  | $ | 7,313,632 |  |  | $ | 593,817 |  |  | $ | — |  |  | $ | 7,907,449 |
U.S. treasury securities |  | 550,800 |  |  | — |  |  | — |  |  | — |  |  | 550,800 |
Bonds |  | — |  |  | 418,069 |  |  | — |  |  | — |  |  | 418,069 |
Total fixed income investments |  | 550,800 |  |  | 7,731,701 |  |  | 593,817 |  |  | — |  |  | 8,876,318 |
Partnership interests |  | — |  |  | — |  |  | — |  |  | 2,000,380 |  |  | 2,000,380 |
Equity securities |  | 28,603 |  |  | 2,615 |  |  | 1,829,928 |  |  | — |  |  | 1,861,146 |
Total investments, at fair value |  | 579,403 |  |  | 7,734,316 |  |  | 2,423,745 |  |  | 2,000,380 |  |  | 12,737,844 |
Derivatives-foreign currency forward contracts |  | — |  |  | 2,995 |  |  | — |  |  | — |  |  | 2,995 |
Total assets, at fair value |  | $ | 579,403 |  |  | $ | 7,737,311 |  |  | $ | 2,423,745 |  |  | $ | 2,000,380 |  |  | $ | 12,740,839 |
Liabilities, at fair value |  |  |  |  |  |  |  |  |  |
Loan obligations of CLOs |  | $ | — |  |  | $ | (9,672,189) |  |  | $ | — |  |  | $ | — |  |  | $ | (9,672,189) |
Derivatives: |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | — |  |  | (2,888) |  |  | — |  |  | — |  |  | (2,888) |
Asset swaps |  | — |  |  | — |  |  | (1,846) |  |  | — |  |  | (1,846) |
Total derivative liabilities, at fair value |  | — |  |  | (2,888) |  |  | (1,846) |  |  | — |  |  | (4,734) |
Total liabilities, at fair value |  | $ | — |  |  | $ | (9,675,077) |  |  | $ | (1,846) |  |  | $ | — |  |  | $ | (9,676,923) |
Schedule of Changes in the Fair Value of the Level III Investments, Liabilities | The following tables set forth a summary of changes in the fair value of the Level III measurements:
Level III Assets of the Company |  | Equity Securities |  | Fixed Income |  |  |  | Contingent Consideration |  | Total |
Balance as of December 31, 2024 |  | $ | 411,179 |  |  | $ | 41,833 |  |  |  |  | $ | (17,550) |  |  | $ | 435,462 |  |
Established in connection with acquisition (see Note 8) |  | — |  |  | — |  |  |  |  | (465,080) |  |  | (465,080) |  |
Purchases(1) |  | 10,546 |  |  | 1,530 |  |  |  |  | — |  |  | 12,076 |  |
Sales/settlements(2) |  | — |  |  | (23,657) |  |  |  |  | — |  |  | (23,657) |  |
Change in fair value |  | — |  |  | — |  |  |  |  | (2,324) |  |  | (2,324) |  |
Realized and unrealized appreciation (depreciation), net |  | 4,652 |  |  | (1,044) |  |  |  |  | — |  |  | 3,608 |  |
Balance as of March 31, 2025 |  | $ | 426,377 |  |  | $ | 18,662 |  |  |  |  | $ | (484,954) |  |  | $ | (39,915) |  |
Change in net unrealized appreciation/depreciation and fair value included in earnings related to financial assets and liabilities still held at the reporting date |  | $ | 4,652 |  |  | $ | (372) |  |  |  |  | $ | (2,324) |  |  | $ | 1,956 |  |
Level III Net Assets of Consolidated Funds |  | Equity Securities |  | Fixed Income |  |  |  | Derivatives, Net |  | Total
Balance as of December 31, 2024 |  | $ | 1,829,927 |  |  | $ | 593,817 |  |  |  |  | $ | (1,846) |  |  | $ | 2,421,898 |
Transfer in(3) |  | 1 |  |  | 82,478 |  |  |  |  | — |  |  | 82,479 |
Transfer out(3) |  | — |  |  | (72,264) |  |  |  |  | — |  |  | (72,264) |
Purchases(1) |  | 285 |  |  | 247,859 |  |  |  |  | 124 |  |  | 248,268 |
Sales/settlements(2) |  | (88) |  |  | (267,745) |  |  |  |  | — |  |  | (267,833) |
Realized and unrealized appreciation (depreciation), net |  | 14,782 |  |  | (3,153) |  |  |  |  | 973 |  |  | 12,602 |
Balance as of March 31, 2025 |  | $ | 1,844,907 |  |  | $ | 580,992 |  |  |  |  | $ | (749) |  |  | $ | 2,425,150 |
Change in net unrealized appreciation/depreciation included in earnings related to financial assets and liabilities still held at the reporting date |  | $ | 15,102 |  |  | $ | (2,824) |  |  |  |  | $ | 851 |  |  | $ | 13,129 |
(1)Purchases include paid-in-kind interest and securities received in connection with restructurings. (2)Sales/settlements include distributions, principal redemptions and securities disposed of in connection with restructurings. (3)Transfers in and out include changes in the observability of inputs used in valuations and changes due to the consolidation and deconsolidation of funds.
Level III Assets of the Company |  | Equity Securities |  | Fixed Income |  |  |  |  |  |  |  | Total
Balance as of December 31, 2023 |  | $ | 412,491 |  |  | $ | 126,294 |  |  |  |  |  |  |  |  | $ | 538,785 |
Purchases(1) |  | 30 |  |  | 2,266 |  |  |  |  |  |  |  |  | 2,296 |
Sales/settlements(2) |  | (782) |  |  | (108,360) |  |  |  |  |  |  |  |  | (109,142) |
Realized and unrealized appreciation, net |  | 5,135 |  |  | 1,388 |  |  |  |  |  |  |  |  | 6,523 |
Balance as of March 31, 2024 |  | $ | 416,874 |  |  | $ | 21,588 |  |  |  |  |  |  |  |  | $ | 438,462 |
Change in net unrealized appreciation included in earnings related to financial assets still held at the reporting date |  | $ | 5,135 |  |  | $ | 1,388 |  |  |  |  |  |  |  |  | $ | 6,523 |
Level III Net Assets of Consolidated Funds |  | Equity Securities |  | Fixed Income |  |  |  | Derivatives, Net |  | Total
Balance as of December 31, 2023 |  | $ | 1,190,400 |  |  | $ | 740,113 |  |  |  |  | $ | (1,291) |  |  | $ | 1,929,222 |
Transfer in(3) |  | — |  |  | 91,729 |  |  |  |  | — |  |  | 91,729 |
Transfer out(3) |  | — |  |  | (172,358) |  |  |  |  | — |  |  | (172,358) |
Purchases(1) |  | 154,475 |  |  | 263,706 |  |  |  |  | 46 |  |  | 418,227 |
Sales/settlements(2) |  | — |  |  | (285,911) |  |  |  |  | — |  |  | (285,911) |
Realized and unrealized appreciation (depreciation), net |  | 21,589 |  |  | 2,039 |  |  |  |  | (329) |  |  | 23,299 |
Balance as of March 31, 2024 |  | $ | 1,366,464 |  |  | $ | 639,318 |  |  |  |  | $ | (1,574) |  |  | $ | 2,004,208 |
Change in net unrealized appreciation/depreciation included in earnings related to financial assets and liabilities still held at the reporting date |  | $ | 22,225 |  |  | $ | 1,420 |  |  |  |  | $ | (380) |  |  | $ | 23,265 |
(1)Purchases include paid-in-kind interest and securities received in connection with restructurings. (2)Sales/settlements include distributions, principal redemptions and securities disposed of in connection with restructurings. (3)Transfers in and out include changes in the observability of inputs used in valuations and changes due to the consolidation and deconsolidation of funds.
Schedule of Quantitative Inputs and Assumptions Used for Level III Inputs | The following tables summarize the quantitative inputs and assumptions used for the Company’s and the Consolidated Funds’ Level III measurements as of March 31, 2025:
Level III Measurements of the Company |  | Fair Value |  | Valuation Technique(s) |  | Significant Unobservable Input(s) |  | Range |  | Weighted Average
Assets |  |  |  |  |  |  |  |  |  |
Equity securities |  |  |  |  |  |  |  |  |  |
|  | $ | 180,220 |  |  | Transaction price(1) |  | N/A |  | N/A |  | N/A
|  | 100,000 |  |  | Market yield analysis |  | Market interest rate |  | 8.0% |  | 8.0%
|  | 60,856 |  |  | Market approach |  | Multiple of book value |  | 1.3x - 1.5x |  | 1.4x
|  | 56,273 |  |  | Market approach |  | Multiple of book value |  | 0.7x - 0.9x |  | 0.8x
|  |  |  | Discounted cash flow |  | Discount rate |  | 11.0% - 15.0% |  | 13.0%
|  | 19,344 |  |  | Option pricing model |  | Volatility |  | 35.0% |  | 35.0%
|  | 9,684 |  |  | Market approach |  | Earnings multiple |  | 15.4x |  | 15.4x
Fixed income investments |  |  |  |  |  |  |  |  |  |
|  | 18,492 |  |  | Broker quotes and/or 3rd party pricing services |  | N/A |  | N/A |  | N/A
|  | 170 |  |  | Other |  | N/A |  | N/A |  | N/A
Total assets |  | $ | 445,039 |  |  |  |  |  |  |  |  |
Liabilities |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | (484,954) |  |  | Monte Carlo simulation |  | Discount rate |  | 6.6% - 7.0% |  | 7.0%
|  |  |  |  |  | Volatility |  | 11.1% - 15.1% |  | 14.9%
Total liabilities |  | $ | (484,954) |  |  |  |  |  |  |  |  |
Level III Measurements of the Consolidated Funds |  | Fair Value |  | Valuation Technique(s) |  | Significant Unobservable Input(s) |  | Range |  | Weighted Average
Assets |  |  |  |  |  |  |  |  |  |
Equity securities |  |  |  |  |  |  |  |  |  |
|  | $ | 968,124 |  |  | Discounted cash flow |  | Discount rate |  | 10.0% - 20.0% |  | 12.0%
|  | 869,412 |  |  | Market approach |  | Multiple of book value |  | 1.0x - 1.7x |  | 1.3x
|  | 6,584 |  |  | Market approach |  | EBITDA multiple(2) |  | 5.3x - 35.0x |  | 9.2x
|  | 787 |  |  | Market approach |  | Yield |  | 6.4% - 23.7% |  | 9.8%
Fixed income investments |  |  |  |  |  |  |  |  |  |
|  | 291,675 |  |  | Broker quotes and/or 3rd party pricing services |  | N/A |  | N/A |  | N/A
|  | 287,874 |  |  | Market approach |  | Yield |  | 6.4% - 23.7% |  | 9.9%
|  | 1,443 |  |  | Discounted cash flow |  | Discount rate |  | 14.5% - 20.0% |  | 12.8%
Total assets |  | $ | 2,425,899 |  |  |  |  |  |  |  |  |
Liabilities |  |  |  |  |  |  |  |  |  |
Derivative instruments |  | $ | (749) |  |  | Broker quotes and/or 3rd party pricing services |  | N/A |  | N/A |  | N/A
Total liabilities |  | $ | (749) |  |  |  |  |  |  |  |  |
(1)Transaction price consists of securities purchased or restructured. The Company determined that there was no change to the valuation based on the underlying assumptions used at the closing of such transactions. (2)“EBITDA” in the table above is a non-GAAP financial measure and refers to earnings before interest, tax, depreciation and amortization. The following tables summarize the quantitative inputs and assumptions used for the Company’s and the Consolidated Funds’ Level III measurements as of December 31, 2024:
Level III Measurements of the Company |  | Fair Value |  | Valuation Technique(s) |  | Significant Unobservable Input(s) |  | Range |  | Weighted Average |
Assets |  |  |  |  |  |  |  |  |  |  |
Equity securities |  |  |  |  |  |  |  |  |  |  |
|  | $ | 168,387 |  |  | Transaction price(1) |  | N/A |  | N/A |  | N/A |
|  | 100,000 |  |  | Market approach |  | Yield |  | 8.0% |  | 8.0% |
|  | 57,659 |  |  | Market approach |  | Multiple of book value |  | 1.0x - 1.1x |  | 1.0x |
|  |  |  | Discounted cash flow |  | Discount rate |  | 10.0% - 14.0% |  | 12.0% |
|  | 56,918 |  |  | Market approach |  | Multiple of book value |  | 1.2x - 1.7x |  | 1.4x |
|  | 19,205 |  |  | Option pricing model |  | Volatility |  | 35.0% |  | 35.0% |
|  | 8,489 |  |  | Market approach |  | Earnings multiple |  | 15.4x |  | 15.4x |
|  | 521 |  |  | Discounted cash flow |  | Discount rate |  | 18.5% - 21.5% |  | 20.0% |
Fixed income investments |  |  |  |  |  |  |  |  |  |  |
|  | 22,283 |  |  | Transaction price(1) |  | N/A |  | N/A |  | N/A |
|  | 19,040 |  |  | Broker quotes and/or 3rd party pricing services |  | N/A |  | N/A |  | N/A |
|  | 510 |  |  | Other |  | N/A |  | N/A |  | N/A |
Total assets |  | $ | 453,012 |  |  |  |  |  |  |  |  |  |
Liabilities |  |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | (17,550) |  |  | Monte Carlo simulation |  | Discount rate |  | 6.6% - 6.9% |  | 6.8% |
|  |  |  |  |  | Volatility |  | 11.1% |  | 11.1% |
Total liabilities |  | $ | (17,550) |  |  |  |  |  |  |  |  |  |
Level III Measurements of the Consolidated Funds |  | Fair Value |  | Valuation Technique(s) |  | Significant Unobservable Input(s) |  | Range |  | Weighted Average
Assets |  |  |  |  |  |  |  |  |  |
Equity securities |  |  |  |  |  |  |  |  |  |
|  | $ | 985,109 |  |  | Discounted cash flow |  | Discount rate |  | 10.0% - 20.0% |  | 13.0%
|  | 835,432 |  |  | Market approach |  | Multiple of book value |  | 1.0x - 1.7x |  | 1.4x
|  | 8,598 |  |  | Market approach |  | EBITDA multiple(2) |  | 5.6x - 34.6x |  | 10.7x
|  | 789 |  |  | Other |  | N/A |  | N/A |  | N/A
Fixed income investments |  |  |  |  |  |  |  |  |  |
|  | 308,675 |  |  | Broker quotes and/or 3rd party pricing services |  | N/A |  | N/A |  | N/A
|  | 284,950 |  |  | Market approach |  | Yield |  | 7.4% - 28.6% |  | 9.9%
|  | 192 |  |  | Other |  | N/A |  | N/A |  | N/A
Total assets |  | $ | 2,423,745 |  |  |  |  |  |  |  |  |
Liabilities |  |  |  |  |  |  |  |  |  |
Derivative instruments |  | $ | (1,846) |  |  | Broker quotes and/or 3rd party pricing services |  | N/A |  | N/A |  | N/A
Total liabilities |  | $ | (1,846) |  |  |  |  |  |  |  |  |
(1)Transaction price consists of securities purchased or restructured. The Company determined that there has been no change to the valuation based on the underlying assumptions used at the closing of such transactions. (2)“EBITDA” in the table above is a non-GAAP financial measure and refers to earnings before interest, tax, depreciation and amortization.
Schedule of Investments and Unfunded Commitments Valued Using NAV per Share | The following table summarizes the investments held at fair value and unfunded commitments of the Consolidated Funds interests valued using NAV per share:
|  | As of March 31, 2025 |  | As of December 31, 2024
Investments (held at fair value) |  | $ | 2,318,557 |  |  | $ | 2,000,380 |
Unfunded commitments |  | 1,088,937 |  |  | 932,473 |

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 54B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482134/820-10-35-54B Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-8 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A + Details
Name: | us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration